Cargando…

Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China

BACKGROUND: Effective management of imported cases is an important part of epidemic prevention and control. Hainan Province, China reported 168 coronavirus disease 2019 (COVID-19), including 112 imported cases on February 19, 2020, but successfully contained the epidemic within 1 month. We described...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Biao, Lei, Zi-Ying, Wu, Kun-Liang, He, Jian-Rong, Cao, Hui-Juan, Fu, Juan, Chen, Feng, Chen, Yuan, Chen, Bao, Zhou, Xiao-Li, Huang, Tao, Wu, Tao, Du, Yong-Guo, Chen, Suo-Xian, Xiao, Fu-Rong, Gao, Zhi-Liang, He, Jing, Lin, Feng, Lin, Bing-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569564/
https://www.ncbi.nlm.nih.gov/pubmed/33076968
http://dx.doi.org/10.1186/s40249-020-00755-7
_version_ 1783596753473241088
author Wu, Biao
Lei, Zi-Ying
Wu, Kun-Liang
He, Jian-Rong
Cao, Hui-Juan
Fu, Juan
Chen, Feng
Chen, Yuan
Chen, Bao
Zhou, Xiao-Li
Huang, Tao
Wu, Tao
Du, Yong-Guo
Chen, Suo-Xian
Xiao, Fu-Rong
Gao, Zhi-Liang
He, Jing
Lin, Feng
Lin, Bing-Liang
author_facet Wu, Biao
Lei, Zi-Ying
Wu, Kun-Liang
He, Jian-Rong
Cao, Hui-Juan
Fu, Juan
Chen, Feng
Chen, Yuan
Chen, Bao
Zhou, Xiao-Li
Huang, Tao
Wu, Tao
Du, Yong-Guo
Chen, Suo-Xian
Xiao, Fu-Rong
Gao, Zhi-Liang
He, Jing
Lin, Feng
Lin, Bing-Liang
author_sort Wu, Biao
collection PubMed
description BACKGROUND: Effective management of imported cases is an important part of epidemic prevention and control. Hainan Province, China reported 168 coronavirus disease 2019 (COVID-19), including 112 imported cases on February 19, 2020, but successfully contained the epidemic within 1 month. We described the epidemiological and clinical characteristics of COVID-19 in Hainan and compared these features between imported and local cases to provide information for other international epidemic areas. METHODS: We included 91 patients (56 imported and 35 local cases) from two designated hospitals for COVID-19 in Haikou, China, from January 20 to February 19, 2020. Data on the demographic, epidemiological, clinical and laboratory characteristics were extracted from medical records. Patients were followed until April 21, 2020, and the levels of antibodies at the follow-ups were also analysed by the Wilcoxon matched-pairs signed ranks test. RESULTS: Of the 91 patients, 78 (85.7%) patients were diagnosed within the first three weeks after the first case was identified (Day 1: Jan 22, 2020), while the number of local cases started to increase during the third week. No new cases occurred after Day 29. Fever and cough were two main clinical manifestations. In total, 15 (16.5%) patients were severe, 14 (15.4%) had complicated infections, nine (9.9%) were admitted to the intensive care unit, and three died. The median duration of viral shedding in feces was longer than that in nasopharyngeal swabs (19 days vs 16 days, P = 0.007). Compared with local cases, imported cases were older and had a higher incidence of fever and concurrent infections. There was no difference in outcomes between the two groups. IgG was positive in 92.8% patients (77/83) in the follow-up at week 2 after discharge, while 88.4% patients (38/43) had a reduction in IgG levels in the follow-up at week 4 after discharge, and the median level was lower than that in the follow-up at week 2 (10.95 S/Cut Off (S/CO) vs 15.02 S/CO, P <  0.001). CONCLUSION: Imported cases were more severe than local cases but had similar prognoses. The level of IgG antibodies declined from week 6 to week 8 after onset. The short epidemic period in Hainan suggests that the epidemic could be quickly brought under control if proper timely measures were taken.
format Online
Article
Text
id pubmed-7569564
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75695642020-10-19 Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China Wu, Biao Lei, Zi-Ying Wu, Kun-Liang He, Jian-Rong Cao, Hui-Juan Fu, Juan Chen, Feng Chen, Yuan Chen, Bao Zhou, Xiao-Li Huang, Tao Wu, Tao Du, Yong-Guo Chen, Suo-Xian Xiao, Fu-Rong Gao, Zhi-Liang He, Jing Lin, Feng Lin, Bing-Liang Infect Dis Poverty Short Report BACKGROUND: Effective management of imported cases is an important part of epidemic prevention and control. Hainan Province, China reported 168 coronavirus disease 2019 (COVID-19), including 112 imported cases on February 19, 2020, but successfully contained the epidemic within 1 month. We described the epidemiological and clinical characteristics of COVID-19 in Hainan and compared these features between imported and local cases to provide information for other international epidemic areas. METHODS: We included 91 patients (56 imported and 35 local cases) from two designated hospitals for COVID-19 in Haikou, China, from January 20 to February 19, 2020. Data on the demographic, epidemiological, clinical and laboratory characteristics were extracted from medical records. Patients were followed until April 21, 2020, and the levels of antibodies at the follow-ups were also analysed by the Wilcoxon matched-pairs signed ranks test. RESULTS: Of the 91 patients, 78 (85.7%) patients were diagnosed within the first three weeks after the first case was identified (Day 1: Jan 22, 2020), while the number of local cases started to increase during the third week. No new cases occurred after Day 29. Fever and cough were two main clinical manifestations. In total, 15 (16.5%) patients were severe, 14 (15.4%) had complicated infections, nine (9.9%) were admitted to the intensive care unit, and three died. The median duration of viral shedding in feces was longer than that in nasopharyngeal swabs (19 days vs 16 days, P = 0.007). Compared with local cases, imported cases were older and had a higher incidence of fever and concurrent infections. There was no difference in outcomes between the two groups. IgG was positive in 92.8% patients (77/83) in the follow-up at week 2 after discharge, while 88.4% patients (38/43) had a reduction in IgG levels in the follow-up at week 4 after discharge, and the median level was lower than that in the follow-up at week 2 (10.95 S/Cut Off (S/CO) vs 15.02 S/CO, P <  0.001). CONCLUSION: Imported cases were more severe than local cases but had similar prognoses. The level of IgG antibodies declined from week 6 to week 8 after onset. The short epidemic period in Hainan suggests that the epidemic could be quickly brought under control if proper timely measures were taken. BioMed Central 2020-10-19 /pmc/articles/PMC7569564/ /pubmed/33076968 http://dx.doi.org/10.1186/s40249-020-00755-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Wu, Biao
Lei, Zi-Ying
Wu, Kun-Liang
He, Jian-Rong
Cao, Hui-Juan
Fu, Juan
Chen, Feng
Chen, Yuan
Chen, Bao
Zhou, Xiao-Li
Huang, Tao
Wu, Tao
Du, Yong-Guo
Chen, Suo-Xian
Xiao, Fu-Rong
Gao, Zhi-Liang
He, Jing
Lin, Feng
Lin, Bing-Liang
Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title_full Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title_fullStr Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title_full_unstemmed Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title_short Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China
title_sort compare the epidemiological and clinical features of imported and local covid-19 cases in hainan, china
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569564/
https://www.ncbi.nlm.nih.gov/pubmed/33076968
http://dx.doi.org/10.1186/s40249-020-00755-7
work_keys_str_mv AT wubiao comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT leiziying comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT wukunliang comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT hejianrong comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT caohuijuan comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT fujuan comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT chenfeng comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT chenyuan comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT chenbao comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT zhouxiaoli comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT huangtao comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT wutao comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT duyongguo comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT chensuoxian comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT xiaofurong comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT gaozhiliang comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT hejing comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT linfeng comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina
AT linbingliang comparetheepidemiologicalandclinicalfeaturesofimportedandlocalcovid19casesinhainanchina